Antimicrobial susceptibility testing in predicting the presence of carbapenemase genes in Enterobacteriaceae in South Africa

Molecular and Epidemiological Characterization of IMP-Type Metallo-β-Lactamase-Producing Enterobacter cloacae in a Large Tertiary Care Hospital in Japan

(2014) Kayoko Hayakawa et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antibiotic Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae: Systematic Evaluation of the Available Evidence

(2013) Matthew E. Falagas et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Detection of NDM-7 in Germany, a new variant of the New Delhi metallo- -lactamase with increased carbapenemase activity

(2013) S. Gottig et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

First Identification of Novel NDM Carbapenemase, NDM-7, in Escherichia coli in France

(2013) Gaelle Cuzon et al.   PLoS One

Persistence of related bla-IMP-4 metallo-beta-lactamase producing Enterobacteriaceae from clinical and environmental specimens within a burns unit in Australia - a six-year retrospective study

(2013) Grace HY Leung et al.   Antimicrobial Resistance and Infection Control

Emergence of OXA-48 and OXA-181 Carbapenemases among Enterobacteriaceae in South Africa and Evidence ofIn VivoSelection of Colistin Resistance as a Consequence of Selective Decontamination of the Gastrointestinal Tract

(2012) Adrian J. Brink et al.   JOURNAL OF CLINICAL MICROBIOLOGY

A Novel Variant, NDM-5, of the New Delhi Metallo-β-Lactamase in a Multidrug-Resistant Escherichia coli ST648 Isolate Recovered from a Patient in the United Kingdom

(2011) Michael Hornsey et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Carbapenem-Resistant Enterobacteriaceae: Epidemiology and Prevention

(2011) N. Gupta et al.   CLINICAL INFECTIOUS DISEASES

Production of a plasmid-encoded OXA-72 β-lactamase associated with resistance to carbapenems in a clinical isolate Acinetobacter junii

(2011) Felipe Fernández-Cuenca et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

IMP metallo- -lactamase-producing clinical isolates of Enterobacter cloacae in the UK

(2011) V. Shet et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Transfer of KPC-2 Carbapenemase from Klebsiella pneumoniae to Escherichia coli in a Patient: First Case in Europe

(2011) S. N. Richter et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Emergence of New Delhi Metallo-Beta-Lactamase (NDM-1) and Klebsiella pneumoniae Carbapenemase (KPC-2) in South Africa

(2011) A. J. Brink et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Emergence of Metallo- -Lactamase NDM-1-Producing Multidrug-Resistant Escherichia coli in Australia

(2010) L. Poirel et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Carbapenem Heteroresistance in VIM-1-Producing Klebsiella pneumoniae Isolates Belonging to the Same Clone: Consequences for Routine Susceptibility Testing

(2010) M. Tato et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Plasmid-mediated quinolone resistance: an update

(2010) José Manuel Rodríguez-Martínez et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY

Novel VIM Metallo- -Lactamase Variant from Clinical Isolates of Enterobacteriaceae from Algeria

(2009) F. Robin et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

VIM-19, a Metallo- -Lactamase with Increased Carbapenemase Activity from Escherichia coli and Klebsiella pneumoniae

(2009) J.-M. Rodriguez-Martinez et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Characterization of a New Metallo- -Lactamase Gene, blaNDM-1, and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India

(2009) D. Yong et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Spread of OXA-48-Positive Carbapenem-Resistant Klebsiella pneumoniae Isolates in Istanbul, Turkey

(2008) A. Carrer et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Emergence and persistence of integron structures harbouring VIM genes in the Children's Memorial Health Institute, Warsaw, Poland, 1998-2006

(2008) J. A. Patzer et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

The Epidemic of Antibiotic-Resistant Infections: A Call to Action for the Medical Community from the Infectious Diseases Society of America

(2007) B. Spellberg et al.   CLINICAL INFECTIOUS DISEASES